GL1X · GenesisL1 explorer

Research workbench

CDK2 in complex with 3-amino-6-(4-{[2-(DIMETHYLAMINO)ETHYL]SULFAMOYL}- phenyl)-N-pyridin-3-ylpyrazine-2-carboxamide

Analyse CDK2 in complex with 3-amino-6-(4-{[2-(DIMETHYLAMINO)ETHYL]SULFAMOYL}… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4ACM
Type
protein
Length
277 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cyclin-dependent kinase 2
EC
2.7.11.22
UniProt
P24941
Ligands
ACE, 7YG
Pockets
3 · best druggability 0.65

Structure

x-ray diffraction · 1 distinct chain · 35% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACyclin-dependent kinase 2 (EC 2.7.11.22)protein27735% helix, 17% strandP24941

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains A
  • 7YG · 3-amino-6-(4-{[2-(dimethylamino)ethyl]sulfamoyl}phenyl)-N-pyridin-3-ylpyrazine-2-carboxamide · ligand · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12280.650.83267YG
2530.340.7817empty
3570.320.7713empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 4ACM · CDK2 in complex with 3-amino-6-(4-{[2-(DIMETHYLAMINO)ETHYL]SULFAMOYL}-phenyl)-N-pyridin-3… · the same entry in another collection · chain A against A, TM-score 1.00
  • P24941 · AlphaFold monomer V2.0 prediction for cyclin-dependent kinase 2 (P24941) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.